New University of Michigan Tinnitus Discovery — Signal Timing

[Dizzyhead888]

This device is getting a lot of hype because there's plenty of "science" behind it, but that doesn't necessarily mean it's great.

A 13–20 point improvement in TFI scores for 65% of patients is good, and I'll take it, but it's not exactly compelling. I've seen many alternative treatments and research studies on different interventions show similar results on paper.

If someone's tinnitus severity is in the 70s or 80s, it's likely to remain severe. I do wonder, though, if there are any super-responders who experienced improvements of 30 points or more in TFI.

The hopeful part is that using the device for longer than six weeks might lead to greater suppression, but we don't know that yet.

 

[Kam75]

I have said several times in this thread that the device will not be on the market before 2030 in the US and not before 2035 outside the US.

Unfortunately, from what I can see, it seems that my prediction was quite accurate.

So many more years of suffering... But I hope it will be worth it and that we will finally see the light at the end of the tunnel.

 

[NeroRay]

Not surprised about the outcome, but still a bit disappointed. It seems they know it's not ready for human use yet. I don't want to sound pessimistic, but I'm afraid this might end up being shelved.

 

[DimLeb]

Those of you outside the US, would you consider traveling to the US for treatment?

I would consider it, but for some, it just isn't possible. Money, responsibilities, noise exposure, etc. I personally also have ETD and spasm issues so I hesitate to get on an airplane. But who knows in 10 years' time lol.

 

[be6z]

I heard they're short by 3 million, according to Pearson.

I don't think this suggests any real issue. From my understanding, seed funding is quite common for early-stage medical companies, especially when they're preparing for FDA approval. Larger companies usually wait until the 510(k) is at least submitted before getting involved.

They're trying to raise between 1.5 and 3 million, which means they only need around 30 to 60 investors. I may be wrong, but I think they'll get there.

 

[Applejuice]

When I look at the exclusions for the study from ClinicalTrials.gov, it lists:

Exclusion Criteria:

• Diagnosis of Meniere's disease
• Diagnosis of Semicircular Canal Dehiscence
• Unilateral or bilateral cochlear implant recipients
• Diagnosis of acoustic neuroma
• Evidence of retrocochlear disease
• Certain medications and conditions (will be reviewed at screening)

But nothing about excluding multi-tone tinnitus. Where did you find the multi-tone exclusion?

Yeah, you're right. It seems I read it somewhere but can't find the source now. Strange, but I apologize.